1. Home
  2. GWH vs LSB Comparison

GWH vs LSB Comparison

Compare GWH & LSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GWH
  • LSB
  • Stock Information
  • Founded
  • GWH 2011
  • LSB 2002
  • Country
  • GWH United States
  • LSB China
  • Employees
  • GWH N/A
  • LSB N/A
  • Industry
  • GWH Industrial Machinery/Components
  • LSB
  • Sector
  • GWH Miscellaneous
  • LSB
  • Exchange
  • GWH Nasdaq
  • LSB NYSE
  • Market Cap
  • GWH 29.3M
  • LSB 31.5M
  • IPO Year
  • GWH N/A
  • LSB N/A
  • Fundamental
  • Price
  • GWH $2.15
  • LSB $1.33
  • Analyst Decision
  • GWH Hold
  • LSB
  • Analyst Count
  • GWH 5
  • LSB 0
  • Target Price
  • GWH $2.10
  • LSB N/A
  • AVG Volume (30 Days)
  • GWH 55.6K
  • LSB 26.5K
  • Earning Date
  • GWH 05-06-2025
  • LSB 06-21-2025
  • Dividend Yield
  • GWH N/A
  • LSB N/A
  • EPS Growth
  • GWH N/A
  • LSB N/A
  • EPS
  • GWH N/A
  • LSB N/A
  • Revenue
  • GWH $6,295,000.00
  • LSB $79,415,311.00
  • Revenue This Year
  • GWH $204.61
  • LSB $39.33
  • Revenue Next Year
  • GWH $159.83
  • LSB $75.61
  • P/E Ratio
  • GWH N/A
  • LSB N/A
  • Revenue Growth
  • GWH N/A
  • LSB N/A
  • 52 Week Low
  • GWH $1.96
  • LSB $1.26
  • 52 Week High
  • GWH $14.10
  • LSB $11.20
  • Technical
  • Relative Strength Index (RSI)
  • GWH 33.97
  • LSB 30.77
  • Support Level
  • GWH $1.96
  • LSB $1.26
  • Resistance Level
  • GWH $2.74
  • LSB $1.79
  • Average True Range (ATR)
  • GWH 0.26
  • LSB 0.23
  • MACD
  • GWH 0.00
  • LSB -0.06
  • Stochastic Oscillator
  • GWH 24.36
  • LSB 6.00

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. The company design and produce long-duration batteries predominantly using earth-abundant materials.

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: